Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells

J Biol Chem. 2001 Jul 20;276(29):27647-56. doi: 10.1074/jbc.M009614200. Epub 2001 Apr 19.

Abstract

In this report, we explore the mechanisms of targeting of p300 to the interleukin-2 (IL-2) promoter in response to mitogenic and oncogenic molecular signals. Recruitment of p300 by cAMP-responsive element-binding protein-Rel cross-talk at the composite CD28 response element (CD28RE)-TRE element of the IL-2 promoter is essential for promoter inducibility during T-cell activation, and CD28RE-TRE is the exclusive target of the human T-cell lymphotropic virus type I oncoprotein Tax. The intrinsic histone acetyltransferase activity of p300 is dispensable for activation of the IL-2 promoter, and the N-terminal 743 residues contain the minimal structural requirements for synergistic transactivation of the CD28RE-TRE, the IL-2 promoter, and endogenous IL-2 gene expression. Mutational analysis of p300 reveals differential structural requirements for the N-terminal p300 module by individual cis-elements within the IL-2 promoter. These findings provide evidence that p300 assembles at the IL-2 promoter to form an enhanceosome-like signal transduction target that is centrally integrated at the CD28RE-TRE element of the IL-2 promoter through specific protein module-targeted associations in activated T-cells.

MeSH terms

  • Base Sequence
  • CD28 Antigens / genetics
  • Cyclic AMP Response Element-Binding Protein / metabolism*
  • DNA Primers
  • Humans
  • Interleukin-2 / genetics*
  • Jurkat Cells
  • Lymphocyte Activation
  • Mitogens / metabolism*
  • Nuclear Proteins / metabolism*
  • Promoter Regions, Genetic*
  • Receptor Cross-Talk*
  • Signal Transduction*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • Trans-Activators / metabolism*
  • Transcriptional Activation

Substances

  • CD28 Antigens
  • Cyclic AMP Response Element-Binding Protein
  • DNA Primers
  • Interleukin-2
  • Mitogens
  • Nuclear Proteins
  • Trans-Activators